HM15211
A Study of Multiple Doses of HM15211(Efocipegtrutide) in Obese Subjects With NAFLD
Hanmi · Phase 1 · Completed · Enrollment 66
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| HM15211 | n/r | n/r | n/r | n/r |
| Placebo | n/r | n/r | n/r | n/r |
Not shown
- HM15211: endpoint not reported
- Placebo: endpoint not reported